BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Zhang G, Huai Y, Cao Z. Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis. Tumor Biol 2014;35:10111-9. [DOI: 10.1007/s13277-014-2115-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Huang HI, Chen CH, Wang SH, Wang LH, Lin YC. Effects of APE1 Asp148Glu polymorphisms on OPMD malignant transformation, and on susceptibility to and overall survival of oral cancer in Taiwan. Head Neck 2019;41:1557-64. [PMID: 30652382 DOI: 10.1002/hed.25576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Chen Y, Li J, Mo Z. Association between the APEX1 Asp148Glu polymorphism and prostate cancer, especially among Asians: a new evidence-based analysis. Oncotarget 2016;7:52530-40. [PMID: 27248666 DOI: 10.18632/oncotarget.9693] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
3 Azevedo AP, Silva SN, De Lima JP, Reichert A, Lima F, Júnior E, Rueff J. DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms. Oncol Lett 2017;13:4641-50. [PMID: 28599464 DOI: 10.3892/ol.2017.6065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhong JH, Zhao Z, Liu J, Yu HL, Zhou JY, Shi R. Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case-control studies. Onco Targets Ther 2016;9:1499-510. [PMID: 27042118 DOI: 10.2147/OTT.S101456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]